Reward-seeking behavior in human narcolepsy

Journal of Clinical Sleep Medicine

Volumn 7, Issue 3, 2011, Pages 293-300

  Dimitrova, Alexandra ^a   Fronczek, Rolf ^b   Van Der Ploeg, Janneke ^b   Scammell, Thomas ^a   Gautam, Shiva ^a   Pascual Leone, Alvaro ^a   Lammers, Gert Jan ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Addiction; Cataplexy; Hypocretin; Narcolepsy; Orexin; Reward seeking; Risk taking; Sleep; Sleepiness; Substance abuse

Indexed keywords

OREXIN;

ADULT; ALERTNESS; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR; BINGE EATING DISORDER; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HYPOTHESIS; IMPULSIVENESS; MALE; NARCOLEPSY; NETHERLANDS; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; REWARD SEEKING BEHAVIOR; RISK FACTOR; SMOKING; SOMNOLENCE; SUBSTANCE ABUSE; UNITED STATES;

ADULT; ANXIETY DISORDERS; BINGE-EATING DISORDER; CATAPLEXY; DEPRESSIVE DISORDER; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MENTAL DISORDERS; NARCOLEPSY; PSYCHOMETRICS; QUESTIONNAIRES; REWARD; RISK-TAKING;

EID: 79959298593     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/JCSM.1076     Document Type: Article

References (52)

1. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
2. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
3. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66. (Pubitemid 36163996)
4. Harris GC, Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006;29:571-7. (Pubitemid 44416459)
5. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005;437:556-9. (Pubitemid 41613553)
6. Borgland SL, Malenka RC, Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 2004;24:7482-90. (Pubitemid 39166739)
7. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003;23:7-11. (Pubitemid 36050397)
8. Narita M, Nagumo Y, Hashimoto S, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405. (Pubitemid 43237102)
9. Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997;52:27-78. (Pubitemid 27242520)
10. Akimoto H, Honda Y, Takahashi Y. Pharmacotherapy in narcolepsy. Dis Nerv Syst 1960;21:704-6.
11. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
12. Kanbayashi T, Inoue Y, Chiba S, et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002;11:91-3. (Pubitemid 34227220)
13. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed: Diagnostic and coding manual. Westchester, IL, 2005.
14. American Psychiatric Association. (DSM-IV-TR) Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Press, Inc., 2000.
15. Eysenck SB, Pearson PR, Easting G, Allsopp JF. Age norms for impulsiveness, venturesomeness, and empathy in adults. Pers Indiv Differ 1985:613-9.
16. Lejuez CW, Read JP, Kahler CW, et al. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 2002;8:75-84.
17. Lejuez CW, Aklin WM, Jones HA, et al. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 2003;11:26-33. (Pubitemid 36237340)
18. Lejuez CW, Aklin W, Bornovalova M, Moolchan ET. Differences in risk-taking propensity across inner-city adolescent ever- and never-smokers. Nicotine Tob Res 2005;7:71-9. (Pubitemid 40613164)
19. Zuckerman M, Eysenck S, Eysenck HJ. Sensation seeking in England and America: cross-cultural, age, and sex comparisons. J Consult Clin Psychol 1978;46:139-49. (Pubitemid 8298851)
20. Gormally J, Black S, Daston S, Rardin D. The assessment of binge eating severity among obese persons. Addict Behav 1982;7:47-55. (Pubitemid 12131037)
21. Babor TF, Higgins-Biddle J, Monteiro M. AUDIT - Alcohol Use Disorders Identification Test. Guidelines for use in primary care. 2nd edition. In: WHO DoMHaS-DDnWMMa, ed., 2001.
22. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993;88:791-804.
23. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974;131:1121-3.
24. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905-7. (Pubitemid 14002155)
25. Brown BR Jr. Office management of common musculoskeletal pain syndromes. Am Fam Physician 1972;6:92-8.
26. Prieto Ursua L, Llavona-Uribelarrea L. 20 Questions of Gamblers Anonymous: A psychometric study with population of Spain. J Gabl Stud 1998;14:3-15.
27. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
28. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996;67:588-97. (Pubitemid 26382973)
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
30. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005;5:46.
31. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: The Psychological Corporation, 1990.
32. Steer RA, Ranieri W, Beck AT, Clark DA. Further evidence for the validity of the BAI with psychiatric outpatients. J Anxiety Disord 1993;7:195-205. (Pubitemid 23256489)
33. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
34. Lejuez CW, Aklin WM, Zvolensky MJ, Pedulla CM. Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours. J Adolesc 2003;26:475-9. (Pubitemid 36974575)
35. Drummond SP, Bischoff-Grethe A, Dinges DF, Ayalon L, Mednick SC, Meloy MJ. The neural basis of the psychomotor vigilance task. Sleep 2005;28:1059-68. (Pubitemid 41279502)
36. Broughton RJ, Guberman A, Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia 1984;25:423-33. (Pubitemid 14050134)
37. Broughton WA, Broughton RJ. Psychosocial impact of narcolepsy. Sleep 1994;17:S45-9.
38. McKenna BS, Dicjinson DL, Orff HJ, Drummond SP. The effects of one night of sleep deprivation on known-risk and ambiguous-risk decisions. J Sleep Res 2007;16:245-52. (Pubitemid 47283918)
39. Ponz A, Khatami R, Poryazova R, et al. Abnormal activity in reward brain circuits in human narcolepsy with cataplexy. Ann Neurol 2010;67:190-200.
40. Killgore WD, Balkin TJ, Wesensten NJ. Impaired decision making following 49 h of sleep deprivation. J Sleep Res 2006;15:7-13.
41. Killgore WD, Grugle NL, Killgore DB, et al. Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. Aviat Space Environ Med 2008;79:867-74.
42. Kok SW, Overeem S, Visscher TL, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res 2003;11:1147-54. (Pubitemid 41151593)
43. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
44. Fortuyn HA, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep 2008;31:335-41. (Pubitemid 351536505)
45. Dahmen N, Becht J, Engel A, Thommes M, Tonn P. Prevalence of eating disorders and eating attacks in narcolepsy. Neuropsychiatr Dis Treat 2008;4:257-61. (Pubitemid 351460962)
46. Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep 1996;19:75-6. (Pubitemid 26049703)
47. Middelkoop HA, Lammers GJ, Van Hilten BJ, Ruwhof C, Pijl H, Kamphuisen HA. Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 1995;32:286-91.
48. Dodel R, Peter H, Spottke A, et al. Health-related quality of life in patients with narcolepsy. Sleep Med 2007;8:733-41. (Pubitemid 47553545)
49. Dodel R, Peter H, Walbert T, et al. The socioeconomic impact of narcolepsy. Sleep 2004;27:1123-8. (Pubitemid 39331084)
50. Krishnan RR, Volow MR, Miller PP, Carwile ST. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry 1984;141:428-31. (Pubitemid 14194850)
51. Brundin L, Petersen A, Bjorkqvist M, Traskman-Bendz L. Orexin and psychiatric symptoms in suicide attempters. J Affect Disord 2007;100:259-63. (Pubitemid 46818444)
52. Salomon RM, Ripley B, Kennedy JS, et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 2003;54:96-104. (Pubitemid 36859768)